Director Gary S. Roubin filed a Form 4 with the SEC on September 23, 2026, reporting changes in beneficial ownership of Series J and Series K Warrants in InspireMD, Inc. (NASDAQ:NSPR), with transactions dated September 18, 2026.

Key Highlights

  • Reporting person: Gary S. Roubin, listed as a Director of InspireMD, Inc.
  • Transaction code J: Four warrant transactions were reported, all coded "J," with a transaction date of 09/18/2026.
  • Series J Warrants remaining: Following reported transactions, Roubin beneficially owns 15,312 Series J Warrants at an exercise price of $1.3827, and 15,313 Series J Warrants at an exercise price of $0.7674, both held directly.
  • Series K Warrants remaining: Following reported transactions, Roubin beneficially owns 0 Series K Warrants at an exercise price of $1.3827, and 30,624 Series K Warrants at an exercise price of $0.7674, both held directly.
  • Price of derivative security: All four transactions were reported at a price of $0 for the derivative security itself.
  • Underlying security: All warrants carry the right to buy shares of InspireMD Common Stock; each warrant series covers 15,313 or 30,624 shares respectively.

Series J and Series K Warrant Transactions for InspireMD Director Roubin

According to the filing, Gary S. Roubin, a Director at InspireMD, Inc. (NASDAQ:NSPR), reported four derivative security transactions in Table II of the Form 4. All transactions carried transaction code "J" and a transaction date of September 18, 2026. The filing notes that each transaction and its footnotes reference Exhibit 99.1 for additional detail, though that exhibit's content is not reproduced in the filing text provided.

The filing discloses two Series J Warrants (right to buy) with exercise prices of $1.3827 and $0.7674, respectively. For the $1.3827 Series J Warrant, 15,313 shares were disposed of, leaving a balance of 15,312 warrants directly held. For the $0.7674 Series J Warrant, 15,313 shares were disposed of, leaving a balance of 15,313 warrants directly held. Both warrant series reference a date exercisable of May 15, 2023, with the underlying security in each case being Common Stock of InspireMD.

Two Series K Warrants were also reported. For the $1.3827 Series K Warrant, 30,624 derivative securities were disposed of, resulting in a remaining balance of 0. For the $0.7674 Series K Warrant, 30,624 derivative securities were disposed of, leaving 30,624 still directly held. The price of the derivative security for all four transactions is listed as $0. The filing was signed by Michael Lawless as attorney-in-fact for Gary S. Roubin on September 23, 2026.

What Was Disclosed

The filing reports four warrant transactions by InspireMD Director Gary S. Roubin involving Series J and Series K Warrants, all coded "J" and dated September 18, 2026, with resulting beneficial ownership positions in each warrant class disclosed directly.